Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to GT199500023ApriorityCriticalpatent/GT199500023A/en
Publication of GT199500023ApublicationCriticalpatent/GT199500023A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
SE REFIERE A UNA FORMA DE DOSIFICACION DE LIBERACION CONTROLADA DE AZITROMICINA QUE TIENE UN PERFIL DE EFECTOS SECUNDARIOS MEJORADO, A UN PROCEDIMIENTO PARA LA PREPARACIONDE LA FORMA DE DOSIFICACION Y A UN PROCEDIMIENTO DE TRATAMIENTO DE UNA INFECCION MICROBIANA QUE COMPRENDE LA ADMINISTRACION DE AZITROMICINA EN UNA FORMA DE LIBERACION CONTROLADA SEMEJANTE A UN MAMIFERO, INCLUIDO UN PACIENTE HUMANO EN NECESIDAD DE DICHO TRATAMIENTOIT REFERS TO A CONTROLLED RELEASE DOSAGE FORM OF AZITROMYCIN THAT HAS AN IMPROVED SIDE EFFECTS PROFILE, A PROCEDURE FOR PREPARING THE DOSAGE FORM AND A PROCESS FOR THE TREATMENT OF A MICROBIAL INFECTION IN AN AZIT ADMINISTRATION CONTROLLED RELEASE SIMILAR TO A MAMMAL, INCLUDING A HUMAN PATIENT IN NEED OF SUCH TREATMENT
GT199500023A1995-05-171995-05-17
DOSAGE FORMS OF CONTROLLED RELEASE AZITHROMYCIN
GT199500023A
(en)
WATER-SOLUBLE DERIVATIVES OF EPIPODOFILOTOXINA, ITS PREPARATION PROCEDURE, ITS USE AS A MEDICINAL PRODUCT, AND ITS USE INTENDED FOR ANTI-CANCER TREATMENTS.